Morgan Stanley »

Mink Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $545 600 0.91
2023-09-30 $8.9k 8.1k 1.10
2023-06-30 $26k 12k 2.10
2022-12-31 $107 41 2.61
2022-06-30 $0 463 0.00
2022-03-31 $0 90 0.00